Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sansure Biotech's Enterprise Value is ¥7,424 Mil.
Sansure Biotech's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ¥440 Mil. Therefore, Sansure Biotech's EV-to-EBIT ratio for today is 16.88.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Sansure Biotech's Enterprise Value is ¥7,424 Mil.
Sansure Biotech's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥440 Mil. Therefore, Sansure Biotech's EV-to-EBITDA ratio for today is 16.88.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Sansure Biotech's Enterprise Value is ¥7,424 Mil.
Sansure Biotech's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1,203 Mil. Therefore, Sansure Biotech's EV-to-Revenue ratio for today is 6.17.
Sansure Biotech Enterprise Value Historical Data
The historical data trend for Sansure Biotech's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sansure Biotech's Enterprise Value
For the Medical Instruments & Supplies subindustry, Sansure Biotech's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sansure Biotech's Enterprise Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sansure Biotech's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Sansure Biotech's Enterprise Value falls into.
Sansure Biotech Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Sansure Biotech's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sansure Biotech (SHSE:688289) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Sansure Biotech's current Enterprise Value is ¥7,424 Mil.
Sansure Biotech's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥440 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Sansure Biotech's current Enterprise Value is ¥7,424 Mil.
Sansure Biotech's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥440 Mil.
Sansure Biotech's current Enterprise Value is ¥7,424 Mil.
Sansure Biotech's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,203 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sansure Biotech Enterprise Value Related Terms
Thank you for viewing the detailed overview of Sansure Biotech's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Sansure Biotech (SHSE:688289) Business Description
Sansure Biotech Inc is engaged in production and sales of diagnostic reagents and instruments. The company produces Class I medical devices, Class II medical devices, Class III medical devices, general instruments and meters, medical raw materials, medical laboratory equipment and appliances, and medical accessories.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHSE:688289 has been successfully added to your 